The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: A cluster randomized controlled trial (MALTALEP study)

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Richardus, Renate A ^a   Alam, Khorshed ^b   Pahan, David ^b   Feenstra, Sabiena G ^a   Geluk, Annemieke ^c   Richardus, Jan H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Rural Health Program   (Bangladesh)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCG vaccine; Leprosy; M. leprae; Prevention; RCT; Rifampicin; Study protocol

Indexed keywords

BCG VACCINE; RIFAMPICIN;

ABNORMAL URINE COMPOSITION; ABSCESS; ADOLESCENT; ADULT; ARTICLE; ASTHMA; BCG VACCINATION; BLOOD SAMPLING; CHILD; CLUSTER ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DRUG MONITORING; DRUG POTENTIATION; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION PROFILING; HEADACHE; HUMAN; IMMUNOPROPHYLAXIS; IN VITRO STUDY; INFECTION; INFECTION PREVENTION; INJECTION SITE REACTION; INNATE IMMUNITY; KIDNEY FAILURE; LEPROSY; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM LEPRAE; OSTEITIS; OSTEOMYELITIS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RASH; SCAR FORMATION; SCHOOL CHILD; SHOCK; SIDE EFFECT; SINGLE DRUG DOSE; SKIN DEFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

BCG VACCINE; CHEMOPREVENTION; DRUG THERAPY, COMBINATION; HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE; NETHERLANDS; RIFAMPIN;

EID: 84884880962     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-456     Document Type: Article

References (22)

1. Anonymous Global leprosy situation, 2012. Wkly Epidemiol Rec 2012, 87(34):317-328. Anonymous.
2. Moet FJ, Schuring RP, Pahan D, Oskam L, Richardus JH. The prevalence of previously undiagnosed leprosy in the general population of northwest Bangladesh. PLoS Negl Trop Dis 2008, 2(2):e198. 10.1371/journal.pntd.0000198, 2254205, 18301731.
3. Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis 2006, 193(3):346-353. 10.1086/499278, 16388481.
4. Richardus JH, Oskam L. Protecting people against leprosy: Chemoprophylaxis and Immunoprophylaxis (vaccination). Clin Dermatol in press.
5. Merle CS, Cunha SS, Rodrigues LC. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines 2010, 9(2):209-222. 10.1586/erv.09.161, 20109030.
6. Setia MS, Steinmaus C, Ho CS, Rutherford GW. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 2006, 6(3):162-170. 10.1016/S1473-3099(06)70412-1, 16500597.
7. Duppre NC, Camacho LA, da Cunha SS, Struchiner CJ, Sales AM, Nery JA, Sarno EN. Effectiveness of BCG vaccination among leprosy contacts: a cohort study. Transac Royal Soc Trop Med Hyg 2008, 102(7):631-638.
8. Moet FJ, Pahan D, Oskam L, Richardus JH. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ 2008, 336(7647):761-764. 10.1136/bmj.39500.885752.BE, 2287265, 18332051.
9. Schuring RP, Richardus JH, Pahan D, Oskam L. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Vaccine 2009, 27(50):7125-7128. 10.1016/j.vaccine.2009.09.054, 19786134.
10. Bangladesh Bureau of Statistics Bangladesh Population & Housing Census 2011 2011, http://www.bbs.gov.bd (Accessed 9 Sep 2013), Bangladesh Bureau of Statistics.
11. Anonymous WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser 1998, 874:1-43. Anonymous.
12. Anonymous Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines. Lepr Rev 2006, 77(3):1-50. IX, X, Anonymous.
13. Drugs.com Rifampin Side Effects 2013, http://www.drugs.com/sfx/rifampin-side-effects.htm (Accessed 13 Aug 2013), Drugs.com.
14. Grange JM. Complications of bacille Calmette-Guerin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health/PHLS 1998, 1(2):84-88.
15. Mori T, Yamauchi Y, Shiozawa K. Lymph node swelling due to bacille Calmette-Guerin vaccination with multipuncture method. Tuber Lung Dis 1996, 77(3):269-273. 10.1016/S0962-8479(96)90012-X, 8758112.
16. Kroger L, Korppi M, Brander E, Kroger H, Wasz-Hockert O, Backman A, Rapola J, Launiala K, Katila ML. Osteitis caused by bacille Calmette-Guerin vaccination: a retrospective analysis of 222 cases. J Infect Dis 1995, 172(2):574-576. 10.1093/infdis/172.2.574, 7622909.
17. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, Stephan JL, Bernaudin F, Bordigoni P, Turck D, et al. Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics 1996, 98(4 Pt 1):774-778.
18. Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis 1997, 24(6):1139-1146. 10.1086/513642, 9195072.
19. Cunha SS, Alexander N, Barreto ML, Pereira ES, Dourado I, Maroja Mde F, Ichihara Y, Brito S, Pereira S, Rodrigues LC. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial. PLoS Negl Trop Dis 2008, 2(2):e167. 10.1371/journal.pntd.0000167, 2238709, 18270542.
20. Geluk A, Bobosha K, van der Ploeg-van Schip JJ, Spencer JS, Banu S, Martins MV, Cho SN, Franken KL, Kim HJ, Bekele Y, et al. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy. J Immunol 2012, 188(10):4782-4791. 10.4049/jimmunol.1103452, 3345093, 22504648.
21. Corstjens PL, de Dood CJ, van der Ploeg-van Schip JJ, Wiesmeijer KC, Riuttamaki T, van Meijgaarden KE, Spencer JS, Tanke HJ, Ottenhoff TH, Geluk A. Lateral flow assay for simultaneous detection of cellular- and humoral immune responses. Clin Biochem 2011, 44(14-15):1241-1246. 3177995, 21763300.
22. Joosten SA, Goeman JJ, Sutherland JS, Opmeer L, de Boer KG, Jacobsen M, Kaufmann SH, Finos L, Magis-Escurra C, Ota MO, et al. Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun 2012, 13(1):71-82. 10.1038/gene.2011.64, 21956656.